Somewhat Favorable News Coverage Somewhat Unlikely to Affect Simulations Plus (SLP) Share Price
Media headlines about Simulations Plus (NASDAQ:SLP) have been trending somewhat positive recently, according to Accern. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Simulations Plus earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 46.5359066899737 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Several brokerages recently issued reports on SLP. BidaskClub raised Simulations Plus from a “hold” rating to a “buy” rating in a research report on Thursday, October 5th. Zacks Investment Research cut Simulations Plus from a “buy” rating to a “hold” rating in a research report on Wednesday, September 20th.
Shares of Simulations Plus (NASDAQ SLP) opened at $15.90 on Wednesday. The company has a market capitalization of $279.15, a price-to-earnings ratio of 47.50 and a beta of -0.73. Simulations Plus has a fifty-two week low of $8.81 and a fifty-two week high of $17.45.
Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Tuesday, November 14th. The technology company reported $0.06 EPS for the quarter, topping the Zacks’ consensus estimate of $0.05 by $0.01. The business had revenue of $6.30 million for the quarter, compared to analyst estimates of $5.01 million. Simulations Plus had a return on equity of 23.95% and a net margin of 23.94%. equities analysts expect that Simulations Plus will post 0.4 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Monday, November 20th. Investors of record on Monday, November 13th were issued a dividend of $0.06 per share. This is a positive change from Simulations Plus’s previous quarterly dividend of $0.05. This represents a $0.24 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date of this dividend was Friday, November 10th. Simulations Plus’s dividend payout ratio (DPR) is 72.73%.
In other Simulations Plus news, major shareholder Walter S. Woltosz sold 18,500 shares of the business’s stock in a transaction on Wednesday, September 27th. The stock was sold at an average price of $15.45, for a total value of $285,825.00. Following the sale, the insider now directly owns 5,647,916 shares in the company, valued at $87,260,302.20. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 36.93% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Simulations Plus (SLP) Share Price” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-simulations-plus-slp-share-price/1732749.html.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.